ICON PLC Shares Surge 57% Following Financial Restatements

ICON Public Limited Company shares surged 57% in the second quarter of 2026. The recovery followed the release of delayed year-end and first-quarter financial results, which provided market clarity on accounting issues that had previously depressed the stock's value.

In February 2026, the clinical research organization announced it would delay results and restate financial statements for 2023 and 2024 due to revenue overstatements. This announcement triggered a sharp decline in share price during the first quarter of the year.

By August 3, 2026, the company's stock closed at $158.41 per share, representing a market capitalization of $12.13 billion. Greenskeeper Asset Management identified the company as its top performer for the second quarter.